Page last updated: 2024-09-03

cp-166,572 and nad

cp-166,572 has been researched along with nad in 1 studies

Compound Research Comparison

Studies (cp-166,572)	Trials (cp-166,572)	Recent Studies (post-2010) (cp-166,572)	Studies (nad)	Trials (nad)	Recent Studies (post-2010) (nad)
10	0	0	30,121	88	5,663

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lindstad, RI; McKinley-McKee, JS	1

Other Studies

1 other study(ies) available for cp-166,572 and nad

Article	Year
Reversible inhibition of sheep liver sorbitol dehydrogenase by the antidiabetogenic drug 2-hydroxymethyl-4-(4-N,N-dimethylaminosulfonyl-1-piperazino) pyrimidine. FEBS letters, 1997, May-12, Volume: 408, Issue:1 Topics: Aldehyde Reductase; Animals; Enzyme Inhibitors; Fructose; Hydrogen-Ion Concentration; Hypoglycemic Agents; Kinetics; L-Iditol 2-Dehydrogenase; Liver; NAD; Piperazines; Protons; Pyrimidines; Sheep; Sorbitol	1997

Article

Year

Reversible inhibition of sheep liver sorbitol dehydrogenase by the antidiabetogenic drug 2-hydroxymethyl-4-(4-N,N-dimethylaminosulfonyl-1-piperazino) pyrimidine.

FEBS letters, 1997, May-12, Volume: 408, Issue:1

Topics: Aldehyde Reductase; Animals; Enzyme Inhibitors; Fructose; Hydrogen-Ion Concentration; Hypoglycemic Agents; Kinetics; L-Iditol 2-Dehydrogenase; Liver; NAD; Piperazines; Protons; Pyrimidines; Sheep; Sorbitol

1997